Russell Frank Company’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q1 | $74.2M | Buy |
205,814
+88,047
| +75% | +$31.8M | 0.13% | 178 |
|
2015
Q4 | $64.6M | Buy |
117,767
+20,505
| +21% | +$11.2M | 0.11% | 208 |
|
2015
Q3 | $45.2M | Buy |
97,262
+7,473
| +8% | +$3.47M | 0.08% | 257 |
|
2015
Q2 | $45.8M | Buy |
89,789
+21,312
| +31% | +$10.9M | 0.07% | 300 |
|
2015
Q1 | $30.9M | Buy |
68,477
+3,255
| +5% | +$1.47M | 0.06% | 386 |
|
2014
Q4 | $26.6M | Sell |
65,222
-23,317
| -26% | -$9.52M | 0.05% | 454 |
|
2014
Q3 | $31.9M | Sell |
88,539
-19,229
| -18% | -$6.93M | 0.06% | 367 |
|
2014
Q2 | $33.5M | Sell |
107,768
-51,776
| -32% | -$16.1M | 0.06% | 365 |
|
2014
Q1 | $47.9M | Buy |
159,544
+43,885
| +38% | +$13.2M | 0.08% | 275 |
|
2013
Q4 | $32.2M | Sell |
115,659
-87,920
| -43% | -$24.4M | 0.06% | 363 |
|
2013
Q3 | $63.7M | Sell |
203,579
-7,744
| -4% | -$2.42M | 0.11% | 209 |
|
2013
Q2 | $52M | Buy |
+211,323
| New | +$52M | 0.1% | 251 |
|